Importance of various methods of blood pressure measurement in clinical trials

Current Hypertension Reports

Volumn 2, Issue 4, 2000, Pages 362-369

  Palatini, Paolo ^a  

^a Istituto di Medicina Clinica Padova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; HUMAN; HYPERTENSION; METHODOLOGY; REPRODUCIBILITY; REVIEW;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CLINICAL TRIALS; HUMANS; HYPERTENSION; REPRODUCIBILITY OF RESULTS;

EID: 0034244299     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-000-0039-6     Document Type: Article

References (49)

1. Mancia G, Bertinieri G, Grassi G, et al.: Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983, 2: 695-697.
2. Palatini P, Penzo M, Canali C, et al.: Interactive action of the white-coat effect and the blood pressure levels on cardiovascular complications in hypertension. Am J Med 1997, 103: 208-216.
3. Palatini P, Dorigatti F, Roman E, et al.: White coat hypertension. A selection bias? J Hypertens 1998, 16: 977-984.
4. Julius S, Mejia A, Jones K, et al.: "White coat" versus " sustained" borderline hypertension in Tecumseh, Michigan. Hypertension 1990, 16: 617-623.
5. Verdecchia P, Schillaci G, Borgioni C, et al.: Prognostic significance of the white coat effect. Hypertension 1997, 29: 1218-1224.
6. Pickering TG: Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens 1995, 9: 1-11.
7. Weber MA, Neutel JM, Smith DHG, et al.: Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994, 90: 2291-2298.
8. Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory blood pressure. JAMA 1983, 249: 2793-2798.
9. Verdecchia P, Schillaci G, Guerrieri M, et al.: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990, 81: 528-536.
10. Palatini P, Penzo M, Racioppa A, et al.: Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1992, 152: 1855-1860.
11. White WB, Schulman P, McCabe EJ, et al.: Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989, 261: 873-877.
12. American College of Physicians: Automated ambulatory blood pressure and self-measured blood pressure monitoring devices: their role in the diagnosis and management of hypertension. Ann Intern Med 1993, 118: 889-892.
13. Palatini P, Mormino P, Santonastaso M, et al.: Ambulatory blood pressure predicts end-organ damage only in patients with reproducible recordings. J Hypertens 1999, 17: 465-474. This paper reports on the reliability of ambulatory BP monitoring in a large population of mild hypertensive subjects. The authors demonstrate that ambulatory monitoring is a reliable test when mean 24-hour BP is consistent over time. In contrast, a poor performance of the technique can be seen in subjects with poorly reproducible 24-hour B P.
14. Kjeldsen SE, Moan A, Petrin J: Evaluation of self-measured home versus clinic intra-arterial blood pressure. Blood Press 1993, 2: 28-34.
15. Neutel JM, Smith DHG, Weber MA: What are the approaches for evaluating antihypertensive treatment by 24h ambulatory blood pressure monitoring? Blood Press Monit 1999, 4(suppl 2): S23-S28.
16. Staessen JA, Beilin L, Parati G, et al.: Task Force IV: Clinical use of ambulatory blood pressure monitoring. Blood Press Monit 1999, 4: 319-332.
17. Staessen J: Ambulatory blood pressure in clinical trials. Blood Press Monit 2000, 5: 39-42.
18. Des Combes BJ, Porchet M, Waeber B, et al.: Ambulatory blood pressure recordings. Reproducibility and unpredictability. Hypertension 1984, 6: 110-114.
19. Palatini P, Mormino P, Canali C, et al.: Factors affecting ambulatory blood pressure reproducibility: results of the HARVEST trial. Hypertension 1994, 23: 211-216.
20. Conway J, Johnston J, Coats A, et al.: The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. J Hypertens 1988, 6: 111-116.
21. Staessen JA, Thijs L, Mancia G, et al.: Clinical trials with ambulatory blood pressure monitoring: fewer patients needed? Syst-Eur Investigators. Lancet 1994, 344: 1552-1556.
22. Coats AJS: Benefits of ambulatory blood pressure monitoring in the design of antihypertensive drug trials. Blood Press Monit 1996, 1: 157-160.
23. Palatini P, Pessina AC, Dal Palù C: The Hypertension and Ambulatory Recording Venetia Study (HARVEST): a trial on the predictive value of ambulatory blood pressure monitoring for the development of fixed hypertension in patients with borderline hypertension. High Blood Press 1993, 2: 11-18.
24. Palatini P, Graniero G, Mormino P, et al.: Relation between physical training and ambulatory blood pressure in stage I hypertensive patients. Results of the HARVEST Trial. Circulation 1994, 90: 2870-2876.
25. Coca A: The placebo effect in ambulatory blood pressure monitoring. Blood Press Monit 1998, 3: 185-188.
26. Thijs L, Amery A, Clement D, et al.: Ambulatory blood pressure monitoring in elderly patients with isolated systolic hypertension. J Hypertens 1992, 10: 693-699.
27. Gosse P, Promax H, Durandet P, et al.: "White coat" hypertension, no harm for the heart. Hypertension 1993, 22: 766-770.
28. Palatini P, Dorigatti F, Roman E. et al.: White-coat hypertension: a selection bias? J Hypertens 1998, 16: 977-984.
29. Waeber B, Scherrer U, Petrillo A, et al.: Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording. Lancet 1987, 2: 732-734.
30. Palatini P, Mormino P, Santonastaso M, et al.: Target organ damage in stage I hypertensive subjects with white coat and sustained hypertension: Results from the Harvest study. Hypertension 1998, 31: 57-63. This is one of the lagest surveys in patients with borderline hypertension showing that white coat hypertension is associated with increased left ventricular mass and initial left ventricular remodeling. The similar 24-hour BP found in the normotensive participants and the patients with white coat hypertension indicates that cardiac changes are due to white coat hypertension and not to higher ambulatory BP.
31. Staessen JA, Byttebier G, Buntix F, et al.: Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997, 278: 1065-1072.
32. Mancia G, Zanchetti A, Agabiti RE, et al.: Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Circulation 1997, 95: 1464-1470. A prospective study of hypertensive patients with left ventricular hypertrophy. Ambulatory BP appeared to be superior to clinic BP in predicting treatment-induced changes of left ventricular mass.
33. Fenichel RR, Lipicki RJ: On the trough: peak ratio of drug effect in antihypertensive trials. Am J Hypertens 1996, 9: 105S-107S.
34. Elliott HL, Meredith PA: Calculation of trough: peak ratio in the research unit setting: advantages and disadvantages. Am J Hypertens 1996, 9: 71S-75S.
35. Omboni S, Parati G, Zanchetti A, et al.: Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure. Methodological aspects. J Hypertens 1995, 13: 1105-1112.
36. Meredith PA: Trough: peak ratio and smoothness index for antihypertensive agents. Blood Press Monit 1999, 4: 257-262. This is a comprehensive review that focuses on calculation of the trough: peak ratio and smoothness index as methodologies for defining the duration of action of antihypertensive drugs. Advantages and disadvantages encountered with the use of these two indices are discussed.
37. Palatini P, Racioppa A, Raule G, et al.: Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992, 52: 378-383.
38. Diamont M, Idema RN, Vincent HH: The use of Fourier analysis in the calculation of trough: peak ratio from ambulatory blood pressure measurements. J Hum Hypertens 1998, 12: 61-67.
39. Leenen FHH, Fourney A, Notman G, et al.: Persistence after antihypertensive effect after "missed doses" of calcium antagonist with long (amlodipine) versus short (diltiazem) elimination half-life. Br J Clin Pharmacol 1996, 4: 83-88.
40. Zanchetti A: Twenty-four hour ambulatory blood pressure evaluation of antihypertensive agents. J Hypertens 1997, 15(S7): S21-5.
41. Myers MG: Ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. Blood Press Monit 1999, 4: 185-188.
42. Sakuma M, Imay Y, Nagai K, et al.: Reproducibility of home blood pressure measurements of a 1-year period. Am J Hypertens 1997, 10: 798-803.
43. Midanik LT, Resnick B, Hurley LB, et al.: Home blood pressure monitoring for mild hypertension. Pub Health Rep 1991, 106: 85-89.
44. Myers MG: Self-measurement of blood pressure at home: the potential for reporting bias. Blood Press Monit 1998, 3(suppl 1): S19-S22.
45. O'Brien ET, Mee F, Atkins N, et al.: Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the OMRON HEM-705 CP, Philips HP5332 and Nissei DS-175. Blood Press Monit 1996, 1: 55-62.
46. O'Brien ET, Mee F, Atkins N, et al.: Inaccuracy of seven popular sphygmomanometers for home measurements of blood pressure. J Hypertens 1990, 8: 621-634.
47. White WB, Asmar R, Imai Y, et al.: Task force VI: self monitoring of the blood pressure. Blood Press Monit 1999, 4: 343-351.
48. Fernandez-Gonzales R, Gomez-Pajeulo C, Gabriel R, et al.: Effect of verapamil on home self-measurement of blood pressure and heart rate in hypertensive patients. Verapamil Frequency Research Group. Blood Press Monit 2000, 5: 23-30.
49. Celis H, Staessen JA, Buntix F, et al.: Antihypertensive treatment based on home or office blood pressure measurement: protocol of the randomized controlled THOP trial. Blood Press Monit 1998, 3(suppl 1): S29-S35.